DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
Download on the App Store
Screenshot of DeepNewz app showing story detail view.

Biologics License Application News

    Prediction markets for Biologics License Application

    Outcomes of Eli Lilly's attempt to get retatrutide classified as a biologic vs. a regular drug?

    Oct 24, 1:32 AMDec 31, 11:59 PM
    341

    OptionProbability

    Lilly files a Biologics License Application (BLA) for retatrutide

    Lilly files a standard New Drug Application (NDA) for retatrutide

    FDA rejects biologics license application for retatrutide

    7th Circuit rules that retatrutide DOES count as a biologic

    FDA approves retatrutide as a biologic

    50

    50

    50

    41

    41

Latest stories

Latest stories

Join our channels

Get the latest stories live on any device.

  • WhatsApp

    Top Stories

    Join

  • Telegram

    Top Stories

    Join